Pre-Option Novartis Activities. In support of the Pre-Option Novartis Activities, [***], Akcea will supply or cause to be supplied to Novartis during the Option Period, API in the quantities, at the [***], and on such other terms and conditions as set forth on SCHEDULE 1.3.1. In addition, at Novartis’ reasonable written request [***] * ***Confidential Treatment Requested [***] calendar days in advance of [***], Akcea shall [***] to allow Novartis to conduct, [***], an audit of Akcea’s or its Affiliates’ (including CMO) manufacturing facility where such API was made, [***] for Novartis to complete its vendor qualification activities for such API. If, during the Option Period, Novartis notifies Akcea that [***], the Parties will [***] through the CSC [***].
Appears in 3 contracts
Samples: Strategic Collaboration, Option and License Agreement (Akcea Therapeutics, Inc.), Strategic Collaboration, Option and License Agreement (Akcea Therapeutics, Inc.), Strategic Collaboration, Option and License Agreement (Akcea Therapeutics, Inc.)
Pre-Option Novartis Activities. In support of the Pre-Option Novartis Activities, [***], Akcea will supply or cause to be supplied to Novartis during the Option Period, API in the quantities, at the [***], and on such other terms and conditions as set forth on SCHEDULE 1.3.1. In addition, at Novartis’ reasonable written request [***] * ***Confidential Treatment Requested 7 [***] calendar days in advance of [***], Akcea shall [***] to allow Novartis to conduct, [***], an audit of Akcea’s or its Affiliates’ (including CMO) manufacturing facility where such API was made, [***] for Novartis to complete its vendor qualification activities for such API. If, during the Option Period, Novartis notifies Akcea that [***], the Parties will [***] through the CSC [***].
Appears in 1 contract
Samples: Collaboration and Option Agreement